|
|
|
|
|
|
|
M T W Th Fri |
|
21 August, 2026 |
|
|
sponsored by
|
|
|
|
Meet the AI-powered patient you didn’t plan for
|
| The 2026 Future of Health Report makes it clear: AI has reshaped healthcare. Patients who use AI say they trust it nearly as much as their doctor. And they’re ready to walk away from outdated models for a better experience.
You need to meet patients’ needs or risk them disengaging altogether. ZS can help. Built on data from 10,000 healthcare consumers and professionals across three markets, the report shows how life sciences leaders can transform touch points into turning points for patients.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reporting from Endpoints and other outlets has prompted two Republican lawmakers to write a letter calling on the FDA to effectively reject trial data from China. The letter marks an escalation by lawmakers who want to limit China's influence in the global biotech sector. |
|
|
|
Max Bayer |
Senior Reporter, Endpoints News
|
|
|
|
 |
|
Rep. John Moolenaar (R-MI) (Lenin Nolly/Sipa USA/Sipa via AP Images) |
|
|
|
by Max Bayer
|
Two Republican lawmakers are asking the FDA to reject clinical data from China unless a trial site has been recently audited by the agency, and... | |
|
|
|
|
|
|
by Zachary Brennan
|
HHS Secretary Robert F. Kennedy Jr. wants the government to consider softening its recommendations for certain vaccines. The request for information issued Friday, which Kennedy... | |
|
|
|
|
|
 |
|
|
The biopharma industry tipped the scales on cancer research years ago. Where the federal government once played a major role in determining what was studied... | |
|
|
|
 |
|
|
|
by Alex Hoffman, Zachary Brennan, Kyle LaHucik
|
→ Fresh off a new accelerated approval for its melanoma therapy, Replimune has named Michelle DiNapolias chief commercial officer, effective Aug. 18. DiNapoli formerly... | |
|
|
|
 |
|
|
|
by ENDPOINTS |
🏭 Genentech’s new $750M factory: Roche’s Genentech is investing $750 millionin a new drug delivery device facility at its site in Hillsboro, OR, which... | |
|
|
|
|
|
